Details for New Drug Application (NDA): 065275
✉ Email this page to a colleague
NDA 065275 describes IDARUBICIN HYDROCHLORIDE, which is a drug marketed by Fresenius Kabi Usa, Hikma, Meitheal, Rising, Sandoz, and Teva Parenteral, and is included in seven NDAs. It is available from one supplier. Additional details are available on the IDARUBICIN HYDROCHLORIDE profile page.
The generic ingredient in IDARUBICIN HYDROCHLORIDE is idarubicin hydrochloride. There are six drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the idarubicin hydrochloride profile page.
The generic ingredient in IDARUBICIN HYDROCHLORIDE is idarubicin hydrochloride. There are six drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the idarubicin hydrochloride profile page.
Summary for 065275
| Tradename: | IDARUBICIN HYDROCHLORIDE |
| Applicant: | Hikma |
| Ingredient: | idarubicin hydrochloride |
| Patents: | 0 |
Pharmacology for NDA: 065275
| Mechanism of Action | Topoisomerase Inhibitors |
Medical Subject Heading (MeSH) Categories for 065275
Suppliers and Packaging for NDA: 065275
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| IDARUBICIN HYDROCHLORIDE | idarubicin hydrochloride | INJECTABLE;INJECTION | 065275 | ANDA | Hikma Pharmaceuticals USA Inc. | 0143-9217 | 0143-9217-01 | 1 VIAL, GLASS in 1 BOX (0143-9217-01) / 5 mL in 1 VIAL, GLASS |
| IDARUBICIN HYDROCHLORIDE | idarubicin hydrochloride | INJECTABLE;INJECTION | 065275 | ANDA | Hikma Pharmaceuticals USA Inc. | 0143-9218 | 0143-9218-01 | 1 VIAL, GLASS in 1 BOX (0143-9218-01) / 10 mL in 1 VIAL, GLASS |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 1MG/ML | ||||
| Approval Date: | Dec 14, 2006 | TE: | AP | RLD: | No | ||||
Complete Access Available with Subscription
